Germany – Research laboratory services – Framework agreement for in vivo studies on NB-PDX models in mice
A structured breakdown of scope, eligibility requirements, submission steps, and key conditions — extracted directly from the official notice.
Sign in to unlock Bid Fit & AI Opportunity Intelligence
TenderZenith calculates a personalized qualification score against your company profile and extracts structured intelligence from tender documents with your 7-Day Pro Trial (No Credit Card Required).
Contract Description
The Charité - Universitätsmedizin Berlin, Charitéplatz 1, 10117 Berlin is tendering a framework contract for the implementation of in-vivo studies (therapy, characterization or biodistribution/pharmacokinetics studies) on patient-derived neuroblastoma xenograft models in mice ("NB-PDX models"), including the collection of PDX tumor material. This is a framework agreement with only one contractor. There are special requirements according to the Berlin Tendering and Procurement Act (BerlAVG), see tender documents. Further information can be found on the